Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_assertion description "[However, MERTK is overexpressed or ectopically expressed in a wide variety of cancers, including leukemia, non-small cell lung cancer, glioblastoma, melanoma, prostate cancer, breast cancer, colon cancer, gastric cancer, pituitary adenomas, and rhabdomyosarcomas, potentially resulting in the activation of several canonical oncogenic signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_assertion evidence source_evidence_literature NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_assertion SIO_000772 23833304 NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_assertion wasDerivedFrom befree-20150227 NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_assertion wasGeneratedBy ECO_0000203 NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP844006.RAhSuA6tSGaHJWDlhtd9i50knDSMGgbrnx2MN7buJZ9F4130_provenance.